Given our demonstration that AF6 affects the regulation of both cell death and pro-inflammatory signaling pathways, we assessed these effects in other mouse models of liver diseases, including those for acute liver injury, liver fibrosis and diabetes. The gene discussed is AFDN; the disease is Hepatic fibrosis.